WC500169468
WC500169468
WC500169468
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
PRAC member<br />
PRAC alternate<br />
Country<br />
Outcome<br />
restriction<br />
following<br />
evaluation of<br />
e-DoI for the<br />
meeting<br />
Topics on the current Committee<br />
Agenda for which restriction applies<br />
Product/<br />
substance<br />
Ingebjørg Buajordet Norway Full involvement<br />
Karen Pernille Harg Norway Full involvement<br />
Kamila Czajkowska Poland Full involvement<br />
Margarida Guimarães Portugal Full involvement<br />
Roxana Stroe Romania Full involvement<br />
Tatiana Magálová Slovakia Full involvement<br />
Gabriela Jazbec Slovenia Full involvement<br />
Miguel-Angel Maciá Spain Full involvement<br />
Dolores Montero<br />
Corominas<br />
Spain<br />
Full involvement<br />
Ulla Wändel Liminga Sweden Full involvement<br />
Qun-Ying Yue Sweden Full involvement<br />
June Munro Raine Chair Full involvement<br />
Julie Williams UK Full involvement<br />
Rafe Suvarna UK Full involvement<br />
Independent<br />
scientific experts<br />
nominated by the<br />
European<br />
Commission<br />
Country<br />
Outcome<br />
restriction<br />
following<br />
evaluation of e-<br />
DoI for the<br />
meeting:<br />
Topics on the current Committee<br />
Agenda for which restriction<br />
applies<br />
Product/<br />
substance<br />
Jane Ahlqvist Rastad<br />
Marie Louise De Bruin<br />
Stephen Evans<br />
Brigitte Keller-<br />
Stanislawski<br />
Hervé Le Louet<br />
Not applicable<br />
Cannot act as<br />
Rapporteur or Peer<br />
reviewer for:<br />
Full involvement<br />
Cannot act as<br />
Rapporteur or Peer<br />
reviewer for:<br />
Full involvement<br />
Full involvement<br />
quetiapine, saxagliptin, saxagliptin<br />
metformin, ceftaroline fosamil,<br />
dapagliflozin, exenatide<br />
fluticasone furoate, ofatumumab,<br />
pazopanib, raltegravir, vilanterol,<br />
Lennart Waldenlind<br />
Full involvement<br />
Pharmacovigilance Risk Assessment Committee (PRAC)<br />
EMA/PRAC/324055/2014 Page 71/73